Patent · US Active

CDK inhibitors

US9481691B2 · kind B2 · utility

20Cited by
8References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 2015
Grant dateNov 1, 2016
Priority date—
Expiry dateMay 14, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.